David M. Guttmann, MD, MTR

About Me

I am a radiation oncologist who specializes in treating a variety of cancers, including thoracic and gastrointestinal malignancies, lymphoma, breast cancer, and gynecologic cancers. I use advanced image-guided techniques, such as intensity-modulated radiotherapy, volumetric arc radiotherapy, stereotactic body radiotherapy, and stereotactic radiosurgery. I am part of a team of experts who provide personalized, comprehensive care to patients at MSK Monmouth, in New Jersey.  

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

I always knew that I wanted to be a physician. I was first drawn to oncology from the perspective of science and research. My motivation came from the search for an improved understanding of cancer as a disease, as well as the powerful science and technology harnessed to treat it. As I then began to work with people facing a cancer diagnosis and to understand their experience of living with the disease, I knew I wanted to dedicate my career to improving their lives through a focus on clinical care.

People who have been diagnosed with cancer are often concerned about the many unknowns that lie ahead: What treatments will be recommended? Will they experience side effects? What outcome can they expect? In short, they want to understand how their lives, as well as their loved ones’, will be impacted by cancer.

To help address these questions and concerns, I work alongside my patients and their families, as well as the rest of their medical team. Together, we can ensure their treatment plans are consistent with their values, will aim to heal, and will minimize the chance of harm.

When devising a treatment plan for my patients, it is important to explore all options. This includes, for some, clinical trials. At MSK Monmouth, we offer trials across cancer types that incorporate the newest radiation technologies, including novel combinations of radiotherapy and targeted therapies or immunotherapy.

Once I meet with my patients and their families, I hope they feel comforted by having a clearer understanding of what lies ahead. Our entire team will be available before, during, and after their radiation treatment to ensure they have access to the care they need.

Outside of the office, I enjoy biking, running, cooking, and spending time with my wife and two sons.

  • Clinical Expertise: Intensity-modulated radiotherapy (IMRT); Image-guided radiotherapy (IGRT); Volumetric Modulated Arc Therapy; 3D Conformal Radiotherapy; Electron Beam Therapy; Stereotactic Body Radiotherapy (SBRT); Stereotactic Radiosurgery (SRS); Proton Beam therapy
  • Languages Spoken: English
  • Education: MD, Perelman School of Medicine at the University of Pennsylvania; MTR (Masters in Translational Research), Perelman School of Medicine at the University of Pennsylvania
  • Residencies: Radiation Oncology - Hospital of the University of Pennsylvania


Visit PubMed for a full listing of David M. Guttmann’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.